Literature DB >> 31414961

Can We Use MRI and US to Predict Axillary Node Response in Breast Cancer?

Gary J Whitman1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31414961      PMCID： PMC6776228          DOI： 10.1148/radiol.2019191642

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  7 in total

1.  Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.

Authors:  H M Kuerer; L A Newman; B D Fornage; K Dhingra; K K Hunt; A U Buzdar; F C Ames; M I Ross; B W Feig; G N Hortobagyi; S E Singletary
Journal:  Ann Surg Oncol       Date:  1998-12       Impact factor: 5.344

2.  Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.

Authors:  Rihyeon Kim; Jung Min Chang; Han-Byoel Lee; Su Hyun Lee; Soo-Yeon Kim; Eun Sil Kim; Nariya Cho; Woo Kyung Moon
Journal:  Radiology       Date:  2019-08-13       Impact factor: 11.105

3.  Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

Authors:  Thorsten Kuehn; Ingo Bauerfeind; Tanja Fehm; Barbara Fleige; Maik Hausschild; Gisela Helms; Annette Lebeau; Cornelia Liedtke; Gunter von Minckwitz; Valentina Nekljudova; Sabine Schmatloch; Peter Schrenk; Annette Staebler; Michael Untch
Journal:  Lancet Oncol       Date:  2013-05-15       Impact factor: 41.316

4.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Authors:  Judy C Boughey; Vera J Suman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Henry M Kuerer; Monet Bowling; Teresa S Flippo-Morton; David R Byrd; David W Ollila; Thomas B Julian; Sarah A McLaughlin; Linda McCall; W Fraser Symmans; Huong T Le-Petross; Bruce G Haffty; Thomas A Buchholz; Heidi Nelson; Kelly K Hunt
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

5.  Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.

Authors:  Abigail S Caudle; Wei T Yang; Savitri Krishnamurthy; Elizabeth A Mittendorf; Dalliah M Black; Michael Z Gilcrease; Isabelle Bedrosian; Brian P Hobbs; Sarah M DeSnyder; Rosa F Hwang; Beatriz E Adrada; Simona F Shaitelman; Mariana Chavez-MacGregor; Benjamin D Smith; Rosalind P Candelaria; Gildy V Babiera; Basak E Dogan; Lumarie Santiago; Kelly K Hunt; Henry M Kuerer
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

6.  ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer.

Authors:  Priscilla J Slanetz; Linda Moy; Paul Baron; Roberta M diFlorio; Edward D Green; Samantha L Heller; Anna I Holbrook; Su-Ju Lee; Alana A Lewin; Ana P Lourenco; Bethany Niell; Ashley R Stuckey; Sunita Trikha; Nina S Vincoff; Susan P Weinstein; Monica M Yepes; Mary S Newell
Journal:  J Am Coll Radiol       Date:  2017-11       Impact factor: 5.532

Review 7.  Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.

Authors:  Melissa Pilewskie; Monica Morrow
Journal:  JAMA Oncol       Date:  2017-04-01       Impact factor: 31.777
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.